The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
Stocktwits on MSN
JNJ stock rises on fresh FDA approval for multiple myeloma drug
The latest approval marks the twelfth indication for Darzalex Faspro and fifth in newly diagnosed multiple myeloma. ・The ...
The U.S. Food and Drug Administration (FDA) has approved a drug to control seizures in dogs with idiopathic epilepsy, a type ...
The FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide ...
The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...
The US Food and Drug Administration (FDA) has accepted for priority review Otsuka Pharmaceutical’s new drug application (NDA) ...
Johnson & Johnson received approval from the Food and Drug Administration for a treatment for certain patients with multiple myeloma, an incurable form of blood cancer.
FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.
The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
In early 2025, the FDA was rocked by sweeping layoffs and leadership turnover, raising questions about whether the agency ...
It's not a drug, and it may also have some benefits to quell overeating—here's how tech is transforming mental health care.
An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results